Moderna, Inc.
Explore Moderna
Core profile pages, annual revenue records, and related research hubs for this company.
Moderna, Inc.
Explore Moderna
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: $1.94B
Moderna makes money from product sales of mRNA vaccines and from collaboration, grant, and licensing revenue tied to its mRNA platform and pipeline.
Moderna, Inc.'s growth strategy centers on this advantage: Moderna's advantage is a reusable mRNA platform, rapid design cycle, integrated manufacturing, regulatory experience, and a pipeline that can reuse chemistry, delivery, and clinical infrastructure.